Unlike other available blood and urine tests, the miR Sentinel Prostate Cancer Test characterizes the entire prostate, allowing for more accurate results. If molecular evidence of aggressive prostate cancer is present, the results classify a patient’s condition into categories describing the risk classification of the tumor.
The prostate naturally releases molecules into urine, including several different kinds of genetic material that vary depending on the presence and severity of prostate cancer. We extract and measure these fragments, known as small non-coding RNAs, using gene expression technology and a proprietary algorithm. The miR Sentinel Prostate Cancer Test is a standalone test – it does not rely on PSA or biopsy material.
This result indicates that the patient presents No Molecular Evidence of Prostate Cancer.
This result indicates that the patient presents Molecular Evidence of Low-Risk For Aggressive Prostate Cancer
This result indicates that the patient presents Molecular Evidence of Elevated-Risk For Aggressive Prostate Cancer
miR Scientific’s unique sncRNA extraction and interrogation techniques coupled with an advanced proprietary algorithm will allow physicians to confidently detect and classify prostate cancers with just one urine sample, reducing unnecessary prostate cancer diagnostic procedures and treatments.
Book an appointment with your medical provider and request a prescription for the miR Sentinel Prostate Cancer Test™.
Provide a simple urine sample
in your provider’s office
Your provider will receive comprehensive and accurate results--together you will discuss their meaning and next steps.
The report will be securely delivered to the provider who ordered the test, either via secure fax or email.
The miR Sentinel™ Prostate Cancer Test will be commercially available in most US states as well as Puerto Rico in early 2025. The Test is not currently available in New York.
MiRNA Scientific Collection Kits can be ordered by a healthcare provider over the phone, by contacting MiRNA Scientific’s customer service team at 1 (940) 647-7368.
MiRNA Scientific is currently exploring insurance coverage and Medicare reimbursement with several carriers in the US and Puerto Rico but it may not be a covered benefit. We will submit a claim on your behalf and appeal any potential denials. Once these have been exhausted, patients will have the option to apply for MiRNA Access, a patient assistance program, and then, if there is a balance due, can pay the remaining with a credit card. https://www.mirsentinel.com/insurance-billing
miR's Sentinel™ Prostate Cancer Test is currently only available through a health care provider. Please speak with your physician about possible testing options.
We're here to help! Visit our support center for FAQs and options to connect with a miR Sentinel expert directly.
SUPPORT CENTER
